Both prospective [ 13 – 17 , 38 ] and retrospective data [ 47 ] confirmed an overall trend toward an increased infection risk only in patients treated with higher doses, while the risk of CMV and EBV reactivation was increased in one meta-analysis [ 18 ] but not in another one [ 19 ].
← all excerpts
Rabbit ATG/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel.
1
—
—